Secondary rise of albuminuria under AT1-receptor blockade - what is the potential role of aldosterone escape?

被引：21
作者：
Rump, Lars Christian [1 ]
机构：
[1] Klinikum Ruhr Univ Bochum, Med Klin 1, Marienhosp Herne, D-44625 Herne, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 01期
关键词：
ACE inhibition; albuminuria; aldosterone escape; angiotensin II; AT1-receptor blockade;
D O I：
10.1093/ndt/gfl549
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：5 / 8
页数：5
相关论文
共 34 条
[1]   Nongenomic vascular action of aldosterone in the glomerular microcirculation [J].
Arima, S ;
Kohagura, K ;
Xu, HL ;
Sugawara, A ;
Abe, T ;
Satoh, F ;
Takeuchi, K ;
Ito, S .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09) :2255-2263
[2]   Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole [J].
Arima, S ;
Kohagura, K ;
Xu, HL ;
Sugawara, A ;
Uruno, A ;
Satoh, F ;
Takeuchi, K ;
Ito, S .
HYPERTENSION, 2004, 43 (02) :352-357
[3]   Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study [J].
Bianchi, S ;
Bigazzi, R ;
Campese, VM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) :45-51
[4]   Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats [J].
Blasi, ER ;
Rocha, R ;
Rudolph, AE ;
Blomme, EAG ;
Polly, ML ;
McMahon, EG .
KIDNEY INTERNATIONAL, 2003, 63 (05) :1791-1800
[5]   Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo [J].
Brown, NJ ;
Nakamura, S ;
Ma, LJ ;
Nakamura, I ;
Donnert, E ;
Freeman, M ;
Vaughan, DE ;
Fogo, AB .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1219-1227
[6]   INHIBITION OF ALDOSTERONE BIOSYNTHESIS BY ATRIOPEPTINS IN RAT ADRENAL-CELLS [J].
CAMPBELL, WB ;
CURRIE, MG ;
NEEDLEMAN, P .
CIRCULATION RESEARCH, 1985, 57 (01) :113-118
[7]   Effect of inhibitors of the renin-angiotensin system and other anti hypertensive drugs on renal outcomes: systematic review and meta-analysis [J].
Casas, JP ;
Chua, WL ;
Loukogeorgakis, S ;
Vallance, P ;
Smeeth, L ;
Hingorani, AD ;
MacAllister, RJ .
LANCET, 2005, 366 (9502) :2026-2033
[8]   Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. [J].
Chrysostomou, A ;
Becker, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :925-926
[9]   Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker [J].
Chrysostomou, Anastasia ;
Pedagogos, Eugenia ;
MacGregor, Lachlan ;
Becker, Gavin J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (02) :256-262
[10]   Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure - Results from the Valsartan Heart Failure Trial [J].
Cohn, JN ;
Anand, IS ;
Latini, R ;
Masson, S ;
Chiang, YT ;
Glazer, R .
CIRCULATION, 2003, 108 (11) :1306-1309
1234